How many drugs treat Unstable angina?

Drug Landscape tracks 6 marketed treatments for Unstable angina (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/unstable-angina.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Unstable angina — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Unstable angina (disease) competitive landscape: 6 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

6 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Unstable angina, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Integrilin	EPTIFIBATIDE	Merck & Co.	Platelet Aggregation Inhibitor [EPC]	Integrin alpha-IIb/beta-3	1998-01-01
Plavix	clopidogrel	Generic (originally Sanofi/BMS)	Thienopyridine antiplatelet agent	Cytochrome P450 2B6, P2Y purinoceptor 12, Sodium-dependent serotonin transporter	1997-11-17
Lovenox (Preservative Free)	ENOXAPARIN SODIUM	Sanofi	Low Molecular Weight Heparin	Antithrombin-III	1993-01-01
Lovenox	Lovenox	University of Monastir		Antithrombin-III
Enoxaparin	Enoxaparin	Dana-Farber Cancer Institute		Antithrombin-III
integrilin	integrilin	University of Cincinnati		Integrin alpha-IIb/beta-3

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Dana-Farber Cancer Institute · 1 drug in Unstable angina
Generic (originally Sanofi/BMS) · 1 drug in Unstable angina
Merck & Co. · 1 drug in Unstable angina
Sanofi · 1 drug in Unstable angina
University of Cincinnati · 1 drug in Unstable angina
University of Monastir · 1 drug in Unstable angina

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Unstable angina:

Cite this brief

Drug Landscape (2026). Unstable angina — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/unstable-angina. Accessed 2026-06-10.

Unstable angina full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing